Form 4: Tharimmune Director Acquires 5,000 Stock Options

Tharimmune Director James Gordon Liddy acquired 5,000 stock options with an exercise price of $3.075, increasing his total beneficial ownership of derivative securities to 55,000.

Summary

• James Gordon Liddy, a Director of Tharimmune, Inc. (THAR), acquired 5,000 stock options.
• The transaction occurred on November 3, 2025.
• Each option has an exercise price of $3.075.
• The options become exercisable on November 3, 2025, and expire on November 3, 2035.
• Following this acquisition, Mr. Liddy beneficially owns 55,000 derivative securities.
• The underlying security for these options is Common Stock, with each option representing one share.

Sentiment

Score: 6

Explanation: The acquisition of stock options by a director is generally viewed as a positive signal of confidence in the company's future prospects, though it is a routine insider transaction report.

Positives

• A Director acquiring additional stock options can signal confidence in the company's future performance.
• The increase in beneficial ownership aligns the Director's interests more closely with shareholders.

Negatives

• No specific negatives are reported in this Form 4 filing.

Risks

• This Form 4 filing does not contain information regarding company-specific risks.

Future Outlook

This Form 4 filing does not provide forward-looking statements or guidance regarding the company's future performance.

Industry Context

This insider transaction is a routine disclosure required by the SEC for directors, officers, and significant shareholders. It reflects an individual's decision regarding their personal equity holdings rather than a broader industry trend or competitive action.

Related Party Transactions

• The acquisition of stock options by James Gordon Liddy, a Director of Tharimmune, Inc., constitutes a related party transaction as it involves an insider of the company.

Stakeholder Impact

• Shareholders: May view the director's increased equity stake as a positive indicator of management confidence, potentially influencing investor sentiment.

Next Steps

• The reporting person may choose to exercise the acquired stock options at any time between the exercisable date and the expiration date.

Key Dates

Keywords

Tharimmune, THAR, Form 4, Insider Trading, Stock Options, Director, James Gordon Liddy, Beneficial Ownership, Equity Acquisition